Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D04HVB
|
||||
Former ID |
DIB016001
|
||||
Drug Name |
Panomifene
|
||||
Synonyms |
Panomifine; EGIS-5650
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Cancer [ICD9: 140-229; ICD10:C00-C96] | Discontinued in Phase 2 | [545192] | ||
Company |
EGIS Gyogyszergyar RT
|
||||
Structure |
Download2D MOL |
||||
Formula |
C25H24F3NO2
|
||||
Canonical SMILES |
C(=C(\c1ccc(cc1)OCCNCCO)/c1ccccc1)(/C(F)(F)F)\c1ccccc1
|
||||
CAS Number |
CAS 77599-17-8
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Estrogen receptor | Target Info | Modulator | [534524] | |
Pathway Interaction Database | Regulation of nuclear SMAD2/3 signaling | ||||
Signaling events mediated by HDAC Class II | |||||
Plasma membrane estrogen receptor signaling | |||||
LKB1 signaling events | |||||
Regulation of Telomerase | |||||
ATF-2 transcription factor network | |||||
AP-1 transcription factor network | |||||
FOXM1 transcription factor network | |||||
Validated nuclear estrogen receptor alpha network | |||||
Signaling mediated by p38-alpha and p38-beta | |||||
FOXA1 transcription factor network | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.